Discover Viatris

Viatris Announces Positive Top-Line Results from Second Pivotal Phase 3 VEGA-3 Trial of MR-141 in Presbyopia

Discover Viatris

Viatris Named to TIME’s World’s Most Sustainable Companies 2025 List

Discover Viatris

Same Company, Different Operating System: Carlos’ Neurodiverse Journey

Discover Viatris

Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO™ Low Dose Patch for Birth Control in Women of Childbearing Potential